Enhance your practice with CME and tools that focus on the management of neurological conditions.
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic AD
June 03, 2026
06:00 PM - 07:00 PM CEST
Understanding Variability in Myasthenia Gravis
Henry Kaminski, MD
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
Prem S. Subramanian, MD, PhD
Andrew G. Lee, MD
Valerie Biousse, MD
Neuroinflammation to Network Instability: Translating FAAH/MAGL Biology to NPS
Dani Cabral, MD
Mohammed Q. Al-Sabbagh, MD
Unseen Impact of NPS in AD: Domains and Burden
Beyond Cognition: Managing Alzheimer’s as an Integrated Neurodegenerative–Neuropsychiatric Syndrome
Marwan Sabbagh, MD, FAAN
Advancing Acromegaly Care: Diving Deeper Into Diagnosis, Guideline Application, and Emerging Therapies—A Fireside Chat With Expert Perspectives
June 15, 2026
Chicago, Illinois
NPS Psychosis: Circuits, Treatment, and New Hope
FXIa Remix! Keeping the Flow Without Missing a Beat
Mike Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD
Brian Mac Grory, MB, BCh BAO, MRCP, FAHA, FANA
Amyloid-β Therapies in Practice: Not All Are Created Equal
Tau Therapies and Clinical Translation: Mechanistic Approaches
NPS Agitation: Evidence and Emerging Mechanisms of Management
Rethinking Secondary Stroke Prevention: The Emerging Role of Factor XI Inhibition
Mukul Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD, MSc, FRCPC
Examining the Global Genetic Prevalence of TK2d
Brian P. McDonough, MD, FAAFP
Austin Larson, MD
07:30 AM - 09:00 AM ET
Is Friedreich’s Ataxia Developmental or Degenerative?
Arnulf Koeppen, MD
June 15, 2026 Chicago, Illinois
Microglia Drive Neurodegeneration in Friedreich’s Ataxia
Ryan Quigley
Unpacking the Genetics of Friedreich’s Ataxia
BCMA mRNA CAR-T Shows Durable Benefit in MG
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.